Luis Quintino

Medicine & Life Sciences

1. Glial Cell Line-Derived Neurotrophic Factor 100%
2. Genetic Therapy 66%
3. Parkinson Disease 57%
4. Neurons 46%
5. Transgenes 45%
6. Serum Amyloid A Protein 36%
7. Dependovirus 33%
8. Clustered Regularly Interspaced Short Palindromic Repeats 32%
9. Amyloid beta-Protein Precursor 31%
10. Brain 29%
11. Oxidopamine 29%
12. Neuronal Plasticity 27%
13. Rodentia 24%
14. Genes 23%
15. Alzheimer Disease 23%
16. Trans-Splicing 21%
17. Thymidine Monophosphate 20%
18. Cannabinoid Receptor CB1 17%
19. MicroRNAs 16%
20. Mitogen-Activated Protein Kinase 3 16%
21. Mitogen-Activated Protein Kinase 1 15%
22. Dopamine 14%
23. Neuroprotection 14%
24. Microglia 13%
25. Cytoskeleton 13%
26. Proteins 13%
27. Gene Expression 13%
28. Messenger RNA 12%
29. Glial Cell Line-Derived Neurotrophic Factor Receptors 11%
30. Pathology 9%
31. Therapeutics 9%
32. Nervous System Diseases 9%
33. Tetrahydrofolate Dehydrogenase 9%
34. CRISPR-Associated Protein 9 8%
35. Tyrosine 3-Monooxygenase 8%
36. Phenotype 8%
37. Technology 7%
38. Synapses 6%
39. Microscopy 6%
40. Capsid 6%
41. Corpus Striatum 6%
42. Transcriptional Activation 6%
43. Safety 6%
44. Nerve Growth Factors 5%
45. Transcription Activator-Like Effectors 5%
46. Trimethoprim 5%
47. Genetically Modified Animals 5%
48. Axon Initial Segment 5%
49. Gene Editing 5%
50. alpha-Synuclein 5%